A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trials
J. Francart, E. Vaes, S. Henrard, C. Legrand, P. Baas, R. Gaafar, J.P. van Meerbeeck, R. Sylvester, A. RobertVolume:
45
Year:
2009
Language:
english
Pages:
2312
DOI:
10.1016/j.ejca.2009.04.028
File:
PDF, 323 KB
english, 2009